Jeffrey Borgia to Erlotinib Hydrochloride
This is a "connection" page, showing publications Jeffrey Borgia has written about Erlotinib Hydrochloride.
Connection Strength
0.653
-
The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 2018 03 20; 18(1):310.
Score: 0.608
-
Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma. Cancer Res. 2020 10 01; 80(19):4224-4232.
Score: 0.045